Gerd Ascher

This inventor holds 29 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 9 EPO patents, primarily in Antibacterial Compounds. Top assignees: Biochemie Gesellschaft M.b.h, Sandoz Gmbh, Biochemie Gmbh. Active years: 1977-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerd Ascher. Retrieved from https://idiyas.com/inventor/gerd-ascher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 2)

% Patents Active = 79.3

CIPO Patents = 2

EPO Patents = 9 (Patent Applications = 2)

Average Co-Inventor Count = 2.3

ph-index = 6

Forward Citations = 205(Granted Patents)

Location History:

Vienna, OE (1977)
Worgl, AT (1981 - 1991)
Kundl/Tirol, AT (2010)
Kundl, AT (1992 - 2012)

Company Filing History:

10 out of 55

Biochemie Gesellschaft M.b.h

Nabriva Therapeutics Ag

patents

5. 3 out of 3

Nabriva Therapeutics Forschungs Gmbh

patents

Years Active: 1977-2012

Loading Chart...

Areas of Expertise:

Antibacterial Compounds

Cephalosporins

Pleuromutilin Derivatives

Mutilin Derivatives

Antibiotics

Hydroxyamino Compounds

Acyloxyaminocycloalkyl

3-Vinyl Cephalosporins

Penicillins

Nitrothiazolylimidazolidine

7-Aminocephalosporanic Acid

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8088823 - Tuberculosis treatment using pleuromutilin derivatives (2012-01-03),

2. 7816389 - Organic compounds (2010-10-19),

3. 7790767 - Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group (2010-09-07),

4. 7790749 - [object Object] (2010-09-07),

5. 7569587 - Antibacterial mutilins (2009-08-04),

6. 7534814 - Mutilin derivatives and their use as antibacterials (2009-05-19),

7. 7485632 - Cephalosporins (2009-02-03),

8. 7317101 - Antibacterial cephalosporins (2008-01-08),

9. 6784193 - Mutilin derivatives and their use as antibacterials (2004-08-31),

10. 6753445 - Pleuromutilin derivatives having antibacterial activity (2004-06-22),

11. 6693095 - Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates (2004-02-17),

12. 6531465 - Antibacterial cephalosporins (2003-03-11),

13. 6440957 - Cephalosporines having cyclic aminoguanidine substituents as antibiotics (2002-08-27),

14. 6414140 - Process for the production of 3-vinyl cephalosporins (2002-07-02),

15. 6248881 - Intermediates and process for the production of 3-vinyl cephalosporins (2001-06-19),

Title: The Innovative Journey of Gerd Ascher

Introduction: Gerd Ascher, a distinguished inventor hailing from Kundl, Austria, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Gerd Ascher's latest patents focus on advancements in renewable energy technologies, particularly in the development of solar power systems that are more efficient and cost-effective.

Career Highlights: With a career spanning over two decades, Gerd Ascher has established himself as a leading figure in the renewable energy sector, holding multiple patents and receiving recognition for his pioneering work.

Collaborations: Throughout his career, Gerd Ascher has collaborated with top research institutions and leading companies in the energy industry to further his innovative projects and bring his ideas to fruition.

Conclusion: Gerd Ascher's passion for innovation and his dedication to creating sustainable solutions have solidified his reputation as a visionary inventor in the field of renewable energy.

Profile summary based on public USPTO records.